Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Saperstein

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Muscle & Nerve|September 25, 2003
Late-onset distal muscular dystrophy affecting the posterior calvesJonathan S Katz, Thomas A Rando, Richard J Barohn, et al.
Archives of Neurology|September 17, 2003
Challenges in the identification of cobalamin-deficiency polyneuropathyDavid S Saperstein, Gil I Wolfe, Gary S Gronseth, et al.
Frontiers in Neurology|December 5, 2024
Postural orthostatic tachycardia syndrome and other common autonomic disorders are not functional neurologic disordersSvetlana Blitshteyn, Glenn J Treisman, Ilene S Ruhoy, et al.
Annals of Neurology|April 27, 2005
Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositisSteven A Greenberg, Jack L Pinkus, Geraldine S Pinkus, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 4, 2016
Phase I clinical trial of safety of L-serine for ALS patientsTodd D Levine, Robert G Miller, Walter G Bradley, et al.
European Journal of Neurology|February 13, 2023
Phase 2 trial in acetylcholine receptor antibody-positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg studyMamatha Pasnoor, Vera Bril, Todd Levine, et al.
Neurology. Clinical Practice|December 20, 2018
Review process for IVIg treatment: Lessons learned from INSIGHTS neuropathy studyTodd D Levine, Jonathan S Katz, Richard Barohn, et al.
Diagnosis (Berlin, Germany)|April 24, 2020
Diagnosis of mast cell activation syndrome: a global "consensus-2"Lawrence B Afrin, Mary B Ackerley, Linda S Bluestein, et al.
Muscle & Nerve|December 15, 2015
Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridineTed M Burns, Gordon A Smith, Jeffrey A Allen, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Muscle & Nerve|September 25, 2003
Late-onset distal muscular dystrophy affecting the posterior calvesJonathan S Katz, Thomas A Rando, Richard J Barohn, et al.
Archives of Neurology|September 17, 2003
Challenges in the identification of cobalamin-deficiency polyneuropathyDavid S Saperstein, Gil I Wolfe, Gary S Gronseth, et al.
Frontiers in Neurology|December 5, 2024
Postural orthostatic tachycardia syndrome and other common autonomic disorders are not functional neurologic disordersSvetlana Blitshteyn, Glenn J Treisman, Ilene S Ruhoy, et al.
Annals of Neurology|April 27, 2005
Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositisSteven A Greenberg, Jack L Pinkus, Geraldine S Pinkus, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 4, 2016
Phase I clinical trial of safety of L-serine for ALS patientsTodd D Levine, Robert G Miller, Walter G Bradley, et al.
European Journal of Neurology|February 13, 2023
Phase 2 trial in acetylcholine receptor antibody-positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg studyMamatha Pasnoor, Vera Bril, Todd Levine, et al.
Neurology. Clinical Practice|December 20, 2018
Review process for IVIg treatment: Lessons learned from INSIGHTS neuropathy studyTodd D Levine, Jonathan S Katz, Richard Barohn, et al.
Diagnosis (Berlin, Germany)|April 24, 2020
Diagnosis of mast cell activation syndrome: a global "consensus-2"Lawrence B Afrin, Mary B Ackerley, Linda S Bluestein, et al.
Muscle & Nerve|December 15, 2015
Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridineTed M Burns, Gordon A Smith, Jeffrey A Allen, et al.
Pageof 3